(2S,4S,5R,6R)-5-acetamido-6-((1R,2R)-2-((2S,4S,5R,6R)-5-acetamido-2-carboxy-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-yloxy)-1,3-dihydroxypropyl)-2-((2S,3R,4S,5S,6R)-2-((2R,3S,4R,5R,6S)-5-acetamido-6-((2S,3R,4S,5S,6R)-2-((2R,4R,5R,6R)-5-acetamido-6-(6-azidohexyloxy)-4-hydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-4-hydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-4-hydroxytetrahydro-2H-pyran-2-carboxylic acid

ID: ALA4463736

Chembl Id: CHEMBL4463736

PubChem CID: 155530284

Max Phase: Preclinical

Molecular Formula: C56H93N7O37

Molecular Weight: 1456.37

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H]1[C@H](OCCCCCCN=[N+]=[N-])O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@]5(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@@H](O)[C@@H](CO)O[C@]6(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O6)O5)[C@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)[C@@H]1O

Standard InChI:  InChI=1S/C56H93N7O37/c1-19(70)59-31-23(74)11-55(53(85)86,98-45(31)35(77)25(76)13-64)97-28(16-67)38(80)46-32(60-20(2)71)24(75)12-56(99-46,54(87)88)100-48-37(79)27(15-66)91-52(42(48)84)95-44-30(18-69)93-50(34(40(44)82)62-22(4)73)96-47-36(78)26(14-65)90-51(41(47)83)94-43-29(17-68)92-49(33(39(43)81)61-21(3)72)89-10-8-6-5-7-9-58-63-57/h23-52,64-69,74-84H,5-18H2,1-4H3,(H,59,70)(H,60,71)(H,61,72)(H,62,73)(H,85,86)(H,87,88)/t23-,24-,25+,26+,27+,28+,29+,30+,31+,32+,33+,34+,35+,36-,37-,38-,39+,40+,41+,42+,43+,44+,45+,46+,47-,48-,49+,50-,51-,52-,55+,56-/m0/s1

Standard InChI Key:  AEFUWXIDZSTDAP-LMZURUHYSA-N

Alternative Forms

  1. Parent:

    ALA4463736

    ---

Associated Targets(Human)

SIGLEC7 Tchem Sialic acid-binding Ig-like lectin 7 (83 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1456.37Molecular Weight (Monoisotopic): 1455.5611AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wu HR, Anwar MT, Fan CY, Low PY, Angata T, Lin CC..  (2019)  Expedient assembly of Oligo-LacNAcs by a sugar nucleotide regeneration system: Finding the role of tandem LacNAc and sialic acid position towards siglec binding.,  180  [PMID:31351394] [10.1016/j.ejmech.2019.07.046]

Source